The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Activated Oncogenes in B6C3F1 Mouse Liver Tumors: Implications for Risk Assessment
Abstract
The validity of mouse liver tumor end points in assessing the potential hazards of chemical exposure to humans is a controversial but important issue, since liver neoplasia in mice is the most frequent tumor target tissue end point in 2-year carcinogenicity studies. The ability to distinguish between promotion of background tumors versus a genotoxic mechanism of tumor initiation by chemical treatment would aid in the interpretation of rodent carcinogenesis data. Activated oncogenes in chemically induced and spontaneously occurring mouse liver tumors were examined and compared as one approach to determine the mechanism by which chemical treatment caused an increased incidence of mouse liver tumors. Data suggest that furan and furfural caused an increased incidence in mouse liver tumors at least in part by induction of novel weakly activating point mutations in ras genes even though both chemicals did not induce mutations in Salmonella assays. In addition to ras oncogenes, two activated raf genes and four non- ras transforming genes were detected. The B6C3F1 mouse liver may thus provide a sensitive assay system to detect various classes of proto-oncogenes that are susceptible to activation by carcinogenic insult. As illustrated with mouse liver tumors, analysis of activated oncogenes in spontaneously occurring and chemically induced rodent tumors will provide information at a molecular level to aid in the use of rodent carcinogenesis data for risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
McCann, J., Choi, E., Yamasaki, E., & Ames, B. N. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.12.5135 · Cited by 3,323
CELLULAR ONCOGENES AND RETROVIRUSES
Bishop, J. M. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001505 · Cited by 1,641
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., & Barbacid, M. (1985) · Nature · doi:10.1038/315382a0 · Cited by 820
Prediction of Chemical Carcinogenicity in Rodents from in Vitro Genetic Toxicity Assays
Tennant, R. W., Margolin, B. H., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., et al. (1987) · Science · doi:10.1126/science.3554512 · Cited by 811
Furth, M. E., Davis, L. J., Fleurdelys, B., & Scolnick, E. M. (1982) · Journal of Virology · doi:10.1128/jvi.43.1.294-304.1982 · Cited by 800
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
Shih, C., Padhy, L. C., Murray, M., & Weinberg, R. A. (1981) · Nature · doi:10.1038/290261a0 · Cited by 791
Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals
Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., & Zeiger, E. (1986) · Environmental Mutagenesis · doi:10.1002/em.2860080802 · Cited by 761
Ellis, R. W., DeFeo, D., Shih, T. Y., Gonda, M. A., Young, H. A., Tsuchida, N., Lowy, D. R., & Scolnick, E. M. (1981) · Nature · doi:10.1038/292506a0 · Cited by 721
Comparative biochemical properties of normal and activated human ras p21 protein
McGrath, J. P., Capon, D. J., Goeddel, D. V., & Levinson, A. D. (1984) · Nature · doi:10.1038/310644a0 · Cited by 699
The Action of Oncogenes in the Cytoplasm and Nucleus
Weinberg, R. A. (1985) · Science · doi:10.1126/science.2997917 · Cited by 689
Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.
Gibbs, J. B., Sigal, I. S., Poe, M., & Scolnick, E. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.18.5704 · Cited by 609
Biological and biochemical properties of human rasH genes mutated at codon 61
Der, C. J., Finkel, T., & Cooper, G. M. (1986) · Cell · doi:10.1016/0092-8674(86)90495-2 · Cited by 543
Detection of sickle cell beta S-globin allele by hybridization with synthetic oligonucleotides.
Conner, B. J., Reyes, A. A., Morin, C., Itakura, K., Teplitz, R. L., & Wallace, R. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.278 · Cited by 531
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity
Sweet, R. W., Yokoyama, S., Kamata, T., Feramisco, J. R., Rosenberg, M., & Gross, M. (1984) · Nature · doi:10.1038/311273a0 · Cited by 531
Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
Balmain, A., Ramsden, M., Bowden, G. T., & Smith, J. (1984) · Nature · doi:10.1038/307658a0 · Cited by 529
Yuasa, Y., Srivastava, S. K., Dunn, C. Y., Rhim, J. S., Reddy, E. P., & Aaronson, S. A. (1983) · Nature · doi:10.1038/303775a0 · Cited by 381
Self-citationAmino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia
Bos, J. L., Toksoz, D., Marshall, C. J., Verlaan-de Vries, M., Veeneman, G. H., van der Eb, A. J., van Boom, J. H., Janssen, J. W. G., & Steenvoorden, A. C. M. (1985) · Nature · doi:10.1038/315726a0 · Cited by 365
Analysis of the transforming potential of the human H-ras gene by random mutagenesis.
Fasano, O., Aldrich, T., Tamanoi, F., Taparowsky, E., Furth, M., & Wigler, M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.4008 · Cited by 280
Purchase, I. F. H., Longstaff, E., Ashby, J., Styles, J. A., Anderson, D., Lefevre, P. A., & Westwood, F. R. (1976) · Nature · doi:10.1038/264624a0 · Cited by 274
Nucleotide Sequence of the p21 Transforming Protein of Harvey Murine Sarcoma Virus
Dhar, R., Ellis, R. W., Shih, T. Y., Oroszlan, S., Shapiro, B., Maizel, J., Lowy, D., & Scolnick, E. (1982) · Science · doi:10.1126/science.6287572 · Cited by 271
Wiseman, R. W., Stowers, S. J., Miller, E. C., Anderson, M. W., & Miller, J. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5825 · Cited by 250
Self-citationMutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.
Bizub, D., Wood, A. W., & Skalka, A. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6048 · Cited by 229
New human transforming genes detected by a tumorigenicity assay.
Fasano, O., Birnbaum, D., Edlund, L., Fogh, J., & Wigler, M. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1695 · Cited by 219
Isolation of a new human oncogene from a diffuse B-cell lymphoma
Eva, A., & Aaronson, S. A. (1985) · Nature · doi:10.1038/316273a0 · Cited by 211
Self-citationThe Human Homologs of the raf ( mil ) Oncogene Are Located on Human Chromosomes 3 and 4
Bonner, T., O'Brien, S. J., Nash, W. G., Rapp, U. R., Morton, C. C., & Leder, P. (1984) · Science · doi:10.1126/science.6691137 · Cited by 181
Activation of a c-K- ras Oncogene by Somatic Mutation in Mouse Lymphomas Induced by Gamma Radiation
Guerrero, I., Villasante, A., Corces, V., & Pellicer, A. (1984) · Science · doi:10.1126/science.6474169 · Cited by 177
Reynolds, S. H., Stowers, S. J., Maronpot, R. R., Anderson, M. W., & Aaronson, S. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.1.33 · Cited by 175
Self-citationGenetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice
Drinkwater, N. R., & Ginsler, J. J. (1986) · Carcinogenesis · doi:10.1093/carcin/7.10.1701 · Cited by 152
Isolation of ras GTP-binding mutants using an in situ colony-binding assay.
Feig, L. A., Pan, B., Roberts, T. M., & Cooper, G. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4607 · Cited by 148
Finkel, T., Der, C. J., & Cooper, G. M. (1984) · Cell · doi:10.1016/0092-8674(84)90310-6 · Cited by 136
The Oncogenic Activation of Human p21 ras by a Novel Mechanism
Walter, M., Clark, S. G., & Levinson, A. D. (1986) · Science · doi:10.1126/science.3487832 · Cited by 130
Ras p21 proteins with high or low GTPase activity can efficiently transform NIH3T3 cells
Lacal, J. C., Srivastava, S. K., Anderson, P. S., & Aaronson, S. A. (1986) · Cell · doi:10.1016/0092-8674(86)90270-9 · Cited by 112
Self-citationCooper, C. S., Blair, D. G., Oskarsson, M. K., Tainsky, M. A., Eader, L. A., & Woude, G. F. V. (1984) · PubMed · Cited by 104
Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1.
McMahon, G., Hanson, L., Lee, J. J., & Wogan, G. N. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9418 · Cited by 97
Activation of Human raf Transforming Genes by Deletion of Normal Amino-Terminal Coding Sequences
Stanton, V. P., & Cooper, G. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.3.1171 · Cited by 96
Mutations of the ras gene product p21 that abolish guanine nucleotide binding.
Clanton, D. J., Hattori, S., & Shih, T. Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5076 · Cited by 92
Srivastava, S. K., Yuasa, Y., Reynolds, S. H., & Aaronson, S. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.38 · Cited by 76
Self-citationNucleotide Sequence of the Two Rat Cellular rasH Genes
Ruta, M., Wolford, R. G., Dhar, R., Defeo-Jones, D., Ellis, R. W., & Scolnick, E. M. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1706-1710.1986 · Cited by 74
Mouse Cells Contain Two Distinct ras Gene mRNA Species That Can Be Translated into a p21 onc Protein
Ellis, R. W., DeFeo, D., Furth, M. E., & Scolnick, E. M. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.11.1339 · Cited by 67
Detection of a Cellular Oncogene in Spontaneous Liver Tumors of B6C3F1 Mice
Fox, T. R., & Watanabe, P. G. (1985) · Science · doi:10.1126/science.3983645 · Cited by 60
Lacal, J. C., & Aaronson, S. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4214 · Cited by 52
Self-citationNucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene
Reddy, E. P., Lipman, D. J., Andersen, P. R., Tronick, S. R., & Aaronson, S. A. (1985) · Journal of Virology · doi:10.1128/jvi.53.3.984-987.1985 · Cited by 43
Self-citation
Cited by
Ashby, J., & Tennant, R. W. (1988) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(88)90114-0 · Cited by 733
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L., & Palmiter, R. D. (1989) · Cell · doi:10.1016/0092-8674(89)90770-8 · Cited by 697
Ashby, J., & Tennant, R. W. (1991) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(91)90003-e · Cited by 688
Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment
Feron, V. J., Til, H. P., de Vrijer, F., Woutersen, R. A., Cassee, F. R., & van Bladeren, P. J. (1991) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(91)90128-9 · Cited by 501
Oncogene Activation in Chemical Carcinogenesis
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60222-5 · Cited by 388
Metadata
- Authors
- Reynolds, S. H., Stowers, S. J., Patterson, R. M., Maronpot, R. R., Aaronson, S. A., & Anderson, M. W.
- Venue
- Science
- Published
- 1987-09-11
- Volume
- 237
- Issue
- 4820
- Pages
- 1309-1316
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2053813431
- Cited by
- 275
- References
- 43
- FWCI
- 23.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.